BANK OF AMERICA CORP /DE/
BankPosition in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 70858
CHARLOTTE, NC
Position in ARCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$151,206
-$70,751 QoQ
Shares Held
22,501
-21.7% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 133 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ARCT ranks #295 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ARCT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $151,206 | 22,501 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $221,957 | 28,751 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $208,958 | 34,088 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,427,613 | 620,055 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,804,500 | 292,429 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,074,604 | 290,331 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $470,271 | 27,712 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,678,482 | 158,487 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,166,984 | 130,061 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,705,268 | 198,557 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,263,185 | 40,063 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,394,314 | 93,711 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,771,748 | 236,114 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $23,934,115 | 998,503 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,633,779 | 685,954 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,600,351 | 107,986 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $289,032 | 18,363 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,535,963 | 56,972 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,723,401 | 127,625 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $832,803 | 17,430 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $523,638 | 15,474 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $504,932 | 12,226 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $299,971 | 6,915 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $549,977 | 12,820 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $458,846 | 9,817 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $203,442 | 14,970 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||